STOCK TITAN

Walgreen Boots Stock Price, News & Analysis

WBA Nasdaq

Welcome to our dedicated page for Walgreen Boots news (Ticker: WBA), a resource for investors and traders seeking the latest updates and insights on Walgreen Boots stock.

Walgreens Boots Alliance (WBA) serves as a global leader in pharmacy-led healthcare and retail innovation. This news hub provides investors and industry professionals with essential updates on strategic initiatives, financial performance, and operational developments shaping this Fortune 500 company.

Access official press releases and curated analysis covering pharmacy services expansion, healthcare partnerships, and retail optimization strategies. Our repository includes updates on prescription care programs, wholesale distribution milestones, and regulatory developments impacting WBA's international operations.

Key categories include quarterly earnings disclosures, leadership changes, store network updates, and technological advancements in pharmaceutical distribution. Bookmark this page for streamlined tracking of WBA's progress in merging community pharmacy care with modern health solutions across 25+ countries.

Rhea-AI Summary

VillageMD has entered a definitive agreement to acquire Summit Health-CityMD for approximately $8.9 billion, with investments from Walgreens Boots Alliance (WBA) and Cigna (CI). This acquisition aims to enhance integrated healthcare offerings and create a multi-payor platform for quality, affordable care. WBA will invest $3.5 billion to support the acquisition, raising its U.S. Healthcare sales goal for fiscal year 2025 to $14.5 billion to $16.0 billion. The transaction is expected to close in Q1 2023.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.1%
Tags
-
Rhea-AI Summary

Walgreens is celebrating Diabetes Awareness Month by offering complimentary diabetes services from November 9-16. These services include free A1C and blood glucose testing, along with educational support at various locations. The company has trained over 20,000 pharmacists to assist patients with diabetes management. Currently, 96 million American adults have prediabetes, and more than 37 million have diabetes. Walgreens aims to provide accessible healthcare solutions and an extensive range of diabetes-related products and services, reinforcing its commitment to the diabetes community.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.72%
Tags
none
-
Rhea-AI Summary

Walgreens announced an agreement to settle opioid-related lawsuits for approximately $4.95 billion over 15 years. This settlement aims to resolve claims made by states, subdivisions, and tribes, without admitting liability. The company highlighted its commitment to addressing the opioid crisis through various initiatives, including patient education and availability of Naloxone. The frameworks are designed to allow Walgreens to focus on customer health and wellbeing while contributing positively to the ongoing crisis.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
none
Rhea-AI Summary

Western Union (NYSE: WU) and Walgreens (NASDAQ: WBA) announced a renewed five-year agreement, allowing customers to access Western Union's Money Transfer and bill payment services at approximately 9,000 Walgreens locations across the U.S. This partnership reflects both companies' commitment to delivering convenient financial services. Western Union's global network enables fast money transfers, enhancing customer engagement. The collaboration highlights Western Union's ongoing investment in expanding its omni-channel product offerings to meet diverse consumer financial needs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.24%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.66%
Tags
none
-
Rhea-AI Summary

Walgreens Boots Alliance (WBA) has appointed Bryan C. Hanson to its board of directors, effective October 27, 2022. With over 30 years in healthcare and technology, Hanson brings significant expertise to the company, serving on both the compensation and leadership performance committee and the finance and technology committee. Currently, he is the president and CEO of Zimmer Biomet. WBA's executive chairman, Stefano Pessina, and CEO Roz Brewer expressed optimism about his contribution to WBA's consumer-centric healthcare strategy.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.55%
Tags
management
Rhea-AI Summary

Walgreens Boots Alliance (WBA) has declared a quarterly dividend of 48 cents per share, unchanged from the previous quarter and representing a 0.5% increase from the same quarter last year. The payment date is set for December 12, 2022, with record date November 15, 2022. This marks the company's 360th consecutive quarter of dividend payments and 47 years of raised dividends, showcasing its long-standing commitment to shareholder returns.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.55%
Tags
dividends
-
Rhea-AI Summary

Walgreens Boots Alliance (WBA) announced that CEO Roz Brewer and CFO James Kehoe will present at the Credit Suisse 31st Annual Healthcare Conference on November 9, 2022, at 11:00 a.m. Pacific time in Rancho Palos Verdes, California. The presentation will be available via a live webcast on the WBA investor relations website. WBA, a leader in integrated healthcare and retail pharmacy, operates approximately 13,000 locations globally and is committed to improving health services and community well-being.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.45%
Tags
conferences
-
Rhea-AI Summary

Walgreens has announced a significant update to its retail pharmacy operations, removing task-based metrics from performance reviews for its 24,000+ pharmacists. This initiative aims to enhance patient care and experiences by allowing pharmacists to focus on clinical services rather than administrative tasks. The company has invested over $190 million in fiscal year 2022 and plans an additional $265 million for fiscal year 2023 to support its pharmacies. These changes align with Walgreens' broader strategy to improve healthcare delivery and community engagement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.03%
Tags
none
Rhea-AI Summary

Walgreens launched the 2022-2023 Flu Index to track flu activity, showing it is over 10 times higher compared to last season and has doubled in the last two weeks. This initiative aims to encourage flu vaccinations amid rising flu cases across the United States. Notably, Louisiana, Texas, and Mississippi have reported the highest flu activity. The CDC recommends flu shots for everyone aged 6 months and older, especially before the holiday season.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.14%
Tags
none

FAQ

What is the current stock price of Walgreen Boots (WBA)?

The current stock price of Walgreen Boots (WBA) is $11.37 as of May 13, 2025.

What is the market cap of Walgreen Boots (WBA)?

The market cap of Walgreen Boots (WBA) is approximately 9.5B.
Walgreen Boots

Nasdaq:WBA

WBA Rankings

WBA Stock Data

9.51B
712.89M
17.47%
63.53%
7.29%
Pharmaceutical Retailers
Retail-drug Stores and Proprietary Stores
Link
United States
DEERFIELD